# AI Applications in Geriatric Care and Frailty Assessment: A Comprehensive Review

## Executive Summary

This document provides a comprehensive review of artificial intelligence and machine learning applications in geriatric care, with particular focus on frailty assessment, fall risk prediction, delirium detection, polypharmacy management, and outcome prediction in elderly populations. The review synthesizes findings from recent research papers to identify key methodologies, performance metrics, and clinical applications relevant to hybrid reasoning systems in acute care settings.

---

## 1. Frailty Scoring with Machine Learning

### 1.1 Overview of Frailty Assessment

Frailty is a state of increased vulnerability to adverse health outcomes that affects a significant portion of the elderly population. Traditional frailty assessment methods rely on cumulative deficit indices and phenotypic classifications, but machine learning approaches are revolutionizing how we identify and predict frailty.

### 1.2 Frailty Index Prediction Models

#### 1.2.1 Computational Models Using Network Theory

**Network Model of Aging** (Rutenberg et al., 2017)
- Represents health attributes as nodes in a complex network
- Models damage propagation through connected nodes
- Key findings:
  - Frailty Index (FI) calculated as proportion of accumulated deficits
  - Maximum observed FI typically ≤ 0.7 (not theoretical maximum of 1.0)
  - Network exponent α significantly affects mortality rate growth
  - Deficit sensitivity parameter q ≈ 0.3 matches clinical observations

**Dynamical Frailty Index Modeling** (Pridham et al., 2024)
- Analyzes longitudinal transitions in health attributes
- Studies from Health and Retirement Study (HRS) and English Longitudinal Study of Ageing (ELSA)
- Sample: 47,592 individuals with 254,357 total visits
- Key metrics:
  - **Damage rate**: Deficit emergence transitions
  - **Repair rate**: Deficit recovery transitions
  - **Tipping point**: Age ~75 years where damage = repair rates
  - Beyond age 75: Sharp FI increase and mortality risk elevation

#### 1.2.2 Frailty Subdimensions and Factor Analysis

**Multi-dimensional Frailty** (Johnson et al., 2024)
- Dataset: English Longitudinal Study of Ageing (ELSA) Wave 9
- Participants: 4,971 community-dwelling adults aged 65+
- Features: 58 self-reported health deficits

Four identified subdimensions:
1. **Mobility Impairment and Physical Morbidity**
2. **Difficulties in Daily Activities**
3. **Mental Health**
4. **Disorientation in Time**

Performance: Four subdimensions better predict quality of life than single FI scores

#### 1.2.3 Administrative Data-Based Frailty Index

**POSET Theory Application** (Silan et al., 2025)
- Data source: Italian local health authority administrative data
- Cohort: Individuals aged ≥65 years
- Final index: 8 parsimonious variables
  - Age
  - Disability
  - Total hospitalizations
  - Mental disorders
  - Neurological diseases
  - Heart failure
  - Kidney failure
  - Cancer

**Performance on adverse outcomes:**
- Death: AUC 0.854
- Emergency room (highest priority): AUC 0.789
- Hospitalization: AUC 0.664
- Disability onset: AUC 0.771
- Dementia onset: AUC 0.780
- Femur fracture: AUC 0.732

### 1.3 Gait-Based Frailty Assessment

**Deep Learning with IMU Signals** (Arshad et al., 2021)
- Method: Encoding gait signals as images using STFT, CWT, and GAF
- Models tested:
  - SS-CNN (Single Stride CNN): 77.3% accuracy
  - MS-CNN (Multi-Stride CNN): 85.1% accuracy
- Key advantage: MS-CNN captures stride-to-stride variations
- Application: Non-invasive frailty screening

**Clinical Integration** (Wairagkar et al., 2021)
- Three-segment body model with only 2 wearable sensors
- Populations tested:
  - 10 younger healthy adults (YH)
  - 12 older healthy adults (OH)
  - 12 people with Parkinson's disease (PwP)
- Sit-to-stand classification accuracy:
  - YH: 98.67%
  - OH: 94.20%
  - PwP: 91.41%

### 1.4 AI Age Discrepancy as Frailty Marker

**CT-Based Assessment** (Seshadri et al., 2024)
- Study: Kidney tumor patients (599 participants)
- Dataset: 2023 KiTS challenge
- Method: Machine learning analysis of preoperative abdominal CT
- Metric: AI Age Discrepancy = AI-predicted age - chronological age

**Clinical associations:**
- Higher discrepancy → Longer hospital stays
- Higher discrepancy → Lower overall survival rates
- Independent of established risk factors
- Provides insights into biological vs. chronological aging

### 1.5 Frailty and Mortality Prediction

**Fried Physical Frailty Phenotype** (Pridham et al., 2025)
- Datasets: HRS, ELSA, NHANES
- Five FPFP deficits evaluated:
  1. Slow gait
  2. Weakness
  3. Weight loss
  4. Low activity
  5. Exhaustion

**Predictive factors:**
- Frailty Index (FI) consistently outperformed FPFP count
- Chronological age is important predictor
- Current deficit state influences future trajectory
- Missing data handling critical for incomplete assessments

---

## 2. Delirium Prediction in Elderly

### 2.1 Clinical Significance

Delirium represents acute confusional states affecting up to 31% of ICU patients, with higher prevalence in elderly populations. Early detection enables timely interventions and improved outcomes.

### 2.2 Machine Learning-Based Prediction Models

#### 2.2.1 Systematic Review of ICU Delirium Models

**Comprehensive Assessment** (Ruppert et al., 2019)
- Review period: 2014-2019
- Studies included: 20 prediction models (26 distinct models)

**Performance ranges:**
- AUROC: 0.68-0.94
- Specificity: 56.5%-92.5%
- Sensitivity: 59%-90.9%

**Key limitations identified:**
- Most models: Single time-point predictions
- Limited dynamic adaptation during ICU stay
- Lack of real-time actionable predictions
- Gap between model development and clinical deployment

#### 2.2.2 Advanced Deep Learning Architectures

**Large Language Model Approach: DeLLiriuM** (Contreras et al., 2024)
- Architecture: Novel LLM-based prediction using structured EHR
- Training data: 104,303 patients from 195 hospitals
- Databases: eICU, MIMIC-IV, UF Health's IDR

**Performance (external validation):**
- AUROC: 0.77 (95% CI: 0.76-0.78) - eICU dataset
- AUROC: 0.84 (95% CI: 0.83-0.85) - MIMIC-IV dataset
- Validation: 77,543 patients across 194 hospitals

**Key features:**
- Predictions based on first 24 hours ICU data
- Predicts probability of delirium during remaining ICU stay
- Interpretable outputs for clinical decision-making

**Mixture-of-Experts Framework: MANDARIN** (Contreras et al., 2025)
- Architecture: 1.5M-parameter neural network
- Prediction window: 12-72 hours ahead
- Training: 92,734 patients (132,997 ICU admissions)
- Validation sources:
  - 11,719 patients from 15 hospitals (eICU)
  - 304 patients prospective validation (UFH)

**Performance comparison (12-hour lead time):**

Delirium prediction:
- External: AUROC 75.5% vs baseline 68.3%
- Prospective: AUROC 82.0% vs baseline 72.7%

Coma prediction:
- External: AUROC 87.3% vs baseline 72.8%
- Prospective: AUROC 93.4% vs baseline 67.7%

**Multi-branch approach:**
- Accounts for current brain status
- Temporal data integration
- Static data incorporation
- Real-time continuous monitoring capability

#### 2.2.3 Subphenotype Discovery

**Unsupervised Learning Approach** (Zhao & Luo, 2021)
- Dataset: MIMIC-IV
- Method: Clustering to identify delirium subtypes
- Goal: Detect heterogeneous presentations

**Key findings:**
- Distinct clusters within delirium population
- Subgroup-specific feature importance differences
- Improved precision through targeted models
- Heterogeneous medical conditions better accommodated

#### 2.2.4 Transformer-Based Models

**State Space Models** (Silva et al., 2024)
- Architecture comparison: MAMBA vs. Longformer
- Datasets: UFH, MIMIC-IV, eICU
- Validation: 203 hospitals, 140,945 patients

**MAMBA model performance:**
- ABD outcome prediction (12h intervals): AUROC 0.95
- State transition prediction: AUROC 0.79
- Dynamic predictions throughout ICU stay

**Longformer implementation** (Silva & Rashidi, 2023)
- Mean AUROC: 0.953 for brain acuity classification
- Multi-class classification: Coma, delirium, death, or normal
- Real-time deployment capability

#### 2.2.5 Environmental Factors

**Ambient Light and Noise Analysis** (Bandyopadhyay et al., 2023)
- Study period: May 2021 - September 2022
- Participants: 102 ICU patients
- Sensors: Thunderboard, ActiGraph, iPod with AudioTools

**Model performance (1-D CNN):**
- Noise features only: AUC 0.77, Sensitivity 0.60
- Combined noise + light: AUC 0.74, Sensitivity 0.56
- Light features (LSTM): AUC 0.80, Sensitivity 0.60

**Environmental insights:**
- Daytime noise significantly higher than nighttime
- Maximum nighttime noise: Positive predictor
- Minimum daytime noise: Negative predictor
- Nighttime light levels more predictive than daytime
- Environmental factor importance varies with ICU stay duration

### 2.3 Algorithmic Bias in Delirium Prediction

**Fairness Analysis** (Tripathi et al., 2022)
- Datasets: MIMIC-III, academic hospital data
- Focus: Sociodemographic feature impact

**Key concerns:**
- Sex and race impact model performance
- Intersectionality effects: Age, race, socioeconomic factors
- Subgroup performance disparities
- Need for bias mitigation strategies

### 2.4 Delirium in Mild Cognitive Impairment

**Time-Series LSTM Analysis** (Ramamoorthy et al., 2025)
- Dataset: MIMIC-IV v2.2
- Population: Patients with mild cognitive impairment (MCI)

**Risk factors identified:**
- Comorbidity patterns
- Charlson Comorbidity Index (CCI) scores
- Demographic variables
- Time-series vital signs

**Survival analysis:**
- MCI patients with delirium: Markedly reduced survival
- Higher vulnerability compared to non-MCI cohorts
- Critical role of comorbidities in risk assessment

### 2.5 Clinical Risk Prediction Scalability

**Multi-Hospital Deployment** (Sun et al., 2021)
- Hospitals: 4 different EHR systems
- Conditions: Delirium, Sepsis, AKI

**Delirium model performance across sites:**
- AUROC range: 0.82-0.95
- Sensitivity range: 0.763-0.882
- Specificity range: 0.691-0.784

**Scalability approach:**
- Common data representations (syntactic interoperability)
- Automated model calibration process
- No requirement for semantic interoperability
- Generic process for multiple diseases

### 2.6 Postoperative Delirium Phenotypes

**Explainable ML Clustering** (Zheng et al., 2024)
- Population: Elderly surgical patients
- Method: Supervised ML + unsupervised clustering
- Feature space: SHAP importance values

**Approach:**
1. Train predictive model for POD risk
2. Apply SHAP for feature importance
3. Cluster patients in SHAP space
4. Identify phenotypes

**Results:**
- Successfully recovered underlying phenotypes
- Outperformed raw feature space clustering
- Clinically relevant subtypes identified
- Enables personalized treatment strategies

### 2.7 LLM-Based Clinical Risk Assessment

**GPT-4 Comparison Study** (Rezk et al., 2024)
- Models compared: GPT-4 vs. specialized Medical AI

**Findings:**
- GPT-4 deficiencies in positive case identification
- Unreliable probability estimates
- Clinical AI superior accuracy
- LLMs suitable for assistive roles only
- Human oversight remains essential

---

## 3. Geriatric-Specific Risk Models

### 3.1 Mortality Prediction Models

#### 3.1.1 Interpretable ML for MODS

**Multi-Organ Dysfunction Syndrome** (Liu et al., 2020)
- Databases: MIMIC-III, eICU-CRD, PLAGH-S
- Model: XGBoost with SHAP explanations
- Population: Elderly ICU patients with MODS

**Validation performance:**
- MIMIC-III: AUC 0.858, Sens 0.834, Spec 0.705
- eICU-CRD: AUC 0.849, Sens 0.763, Spec 0.784
- PLAGH-S: AUC 0.838, Sens 0.882, Spec 0.691

**Advantages:**
- Outperformed baseline models
- Outperformed clinical scores (SOFA, APACHE)
- Feature importance ranking for mortality risk
- Interpretable for clinical decision-making

#### 3.1.2 Medicare Claims-Based Prediction

**Six-Month Mortality** (Makar et al., 2017)
- Population: Elderly Medicare beneficiaries
- Data: Administrative claims database
- Approach: Multiple ML classifiers tested

**Key findings:**
- ML classifiers substantially outperform existing methods
- Better than Cox Proportional-Hazards Model
- Better than FRAX scores
- Feature engineering incorporating clinical insights crucial
- Applications: End-of-life care, population health management

#### 3.1.3 Geriatric Traumatic Brain Injury

**TBI Mortality Prediction** (Si et al., 2025)
- Dataset: MIMIC-III
- Population: Geriatric TBI patients
- Outcome: 30-day mortality

**Model performance:**
- CatBoost: AUROC 0.867 (95% CI: 0.809-0.922)
- Surpassed traditional scoring systems (GCS)
- Feature selection: 69 → 9 clinically meaningful variables

**Top predictors (SHAP analysis):**
- GCS score (Glasgow Coma Scale)
- Oxygen saturation
- Prothrombin time

#### 3.1.4 Diabetes and Heart Failure Comorbidity

**Dual-Condition Mortality** (Fan et al., 2025)
- Dataset: MIMIC-IV
- Population: 1,478 patients aged 65-90 with DM + HF
- Prediction: Short-term mortality

**Model performance:**
- CatBoost: AUROC 0.863 (test set)
- Features: 19 clinically significant variables
- DREAM algorithm: Posterior risk distributions
- Uncertainty-informed predictions

**Key predictors:**
- APS III (Acute Physiology Score)
- Oxygen flow
- GCS eye component
- Braden Mobility score

#### 3.1.5 Type 2 Diabetes Multiclass Classification

**Remaining Life Prediction** (Desure & Krishna, 2024)
- Cohort: 275,190 diabetic U.S. military Veterans aged ≥65
- Features: 68 potential mortality predictors
- Classes:
  - ≤5 years
  - 5-10 years
  - >10 years

**Model performance:**
- XGBoost: Highest accuracy 53.03%
- Class 3 (>10 years): Acceptable performance
- Class 1 (≤5 years): Significantly low performance
- Class 2 (5-10 years): Worst performance

**Challenges identified:**
- High dimensionality after dummy encoding
- Feature-target class associations complex
- Multiclass formulation difficulty

#### 3.1.6 Automated 5-Year Mortality from Chest CT

**Deep Learning + Radiomics** (Carneiro et al., 2016)
- Data: 48 annotated chest CT scans
- Population: Elderly individuals
- Approaches compared:
  1. Deep learning (unified framework)
  2. Radiomics (hand-crafted features)

**Performance:**
- Deep learning: 68.5% accuracy
- Radiomics: 56-66% accuracy (varies by method)

**Impact:**
- Preventive healthcare applications
- Personalized medicine potential
- Consistency detection in imaging

### 3.2 Surgical Risk Prediction

#### 3.2.1 Postoperative Stroke in Elderly SICU

**MIMIC-Based Prediction** (Li et al., 2025)
- Cohort: 19,085 elderly SICU admissions
- Data: MIMIC-III + MIMIC-IV combined
- Prediction window: First 24 hours ICU stay

**Preprocessing pipeline:**
- SVD imputation for missing data
- Z-score normalization
- One-hot encoding
- ADASYN for class imbalance

**Feature selection:**
- Initial: 80 variables
- Final: 20 predictors (RFECV + SHAP)

**Model performance:**
- CatBoost: AUROC 0.8868 (95% CI: 0.8802-0.8937)
- Comparable to classical methods
- More robust to risk labeling variations

**Top risk factors:**
- Prior cerebrovascular disease
- Serum creatinine
- Systolic blood pressure

#### 3.2.2 Hip Fracture Outcomes

**Multimodal Prediction** (van de Beld et al., 2024)
- Population: Elderly hip fracture patients
- Data sources:
  - Static patient data
  - Pre-operative hip and chest images
  - Per-operative vital signals
  - Medications during surgery

**Model architecture:**
- ResNet for image features
- LSTM for vital signals
- Multimodal fusion

**Explainability:**
- Shapley values for modality contribution
- Modified chain rule for propagation
- Local and global explanations
- Relative modality importance quantification

#### 3.2.3 Hip Fracture Risk from X-ray

**Opportunistic Screening** (Schmarje et al., 2022)
- Study: Osteoporosis in Men (MrOS)
- Participants: 3,108 X-rays (89 incident fractures)
- Prediction horizon: 10-year hip fracture risk

**Performance:**
- FORM model: AUROC 81.44 ± 3.11%
- Significantly outperforms Cox model (70.19 ± 6.58)
- Significantly outperforms FRAX (74.72 ± 7.21)
- Better than hip aBMD-based predictions

**Two-Stage Risk Model** (Sun et al., 2025)
- Datasets: MrOS, SOF, UK Biobank
- Stage 1: Clinical/demographic/functional variables
- Stage 2: DXA-derived imaging features

**Advantages:**
- Higher sensitivity than T-score and FRAX
- Reduced missed cases
- Cost-effective approach
- Adaptable across cohorts

### 3.3 Residential Aged Care

**Survival Modeling** (Susnjak & Griffin, 2023)
- Setting: Australasian residential aged care
- Sample: 11,944 residents across 40 facilities
- Period: July 2017 - August 2023

**Models compared:**
- CoxPH, EN, RR, Lasso, GB, XGB, RF
- Best performers: GB, XGB, RF (C-Index ~0.712)

**XGB calibrated predictions:**
- 6-month survival: AUROC 0.746 (95% CI: 0.744-0.749)
- Calibration: 1, 3, 6, 12-month intervals
- Method: Platt scaling

**Key mortality predictors:**
- Age
- Male gender
- Mobility impairment
- Health status
- Pressure ulcer risk
- Appetite

**Interpretability:**
- SHAP values for feature impact
- Clinical alignment with known risk factors
- Supports resource allocation decisions

### 3.4 COVID-19 in Elderly

**Multi-Objective LLM Approach** (Zhu et al., 2024)
- Model: ChatGLM-based
- Population: COVID-19 patients with vulnerability factors

**Architecture:**
- Multi-objective learning strategy
- First: Predict disease severity
- Second: Predict clinical outcomes (conditioned on severity)
- Missing value adaptation through semantic understanding

**Key advantages:**
- No imputation required for missing values
- Severity prediction informs outcome prediction
- Joint optimization of objectives
- Particularly relevant for elderly with comorbidities

### 3.5 Cognitive Function Assessment

**Wearable Device Data** (Sakal et al., 2023)
- Dataset: NHANES - 2,400+ older adults
- Data: RGB-D and wearable sensors (non-invasive)
- Cognitive domains tested:
  - Processing speed
  - Working memory and attention
  - Immediate and delayed recall
  - Categorical verbal fluency

**Models:** CatBoost, XGBoost, Random Forest

**Performance by cognitive domain:**
- Processing speed/working memory/attention: AUC >0.82
- Immediate and delayed recall: AUC >0.72
- Categorical verbal fluency: AUC >0.68

**Novel finding:**
- Activity and sleep parameters strongly associated with processing speed
- Weaker associations with other cognitive domains
- Potential for continuous monitoring systems

**BCI-Based Detection** (Rutkowski et al., 2025)
- Method: Passive FPVS-EEG with CNN
- Population: Elderly patients
- Approach: Lightweight convolutional neural network

**Advantages:**
- No behavioral responses required
- No task comprehension needed
- Objective working memory assessment
- Independent of confounding factors
- Early cognitive decline detection

---

## 4. Functional Decline Prediction

### 4.1 Fall Risk Assessment

#### 4.1.1 Machine Learning-Based Fall Prediction

**Comprehensive Fall Risk Models** (Multiple Studies)

**Timed Up and Go (TUG) Prediction** (Ma, 2020)
- Method: Video analysis + computer vision
- Input: 3D pose from 2D/3D cameras
- Feature extraction: Gait characteristics from pose series

**Feature selection:**
- Copula entropy for TUG score association
- Most informative gait characteristics selected

**Performance:**
- Interpretable predictions
- Clinical user-friendly explanations
- Associations between gait and fall risk identified

**Bimanual Tapping Association** (Ma, 2020)
- Input: Finger tapping test data + TUG data
- Method: Copula entropy analysis

**Key findings:**
- High associations between finger tapping metrics and TUG score
- Finger tapping features:
  - Number of taps
  - Average interval
  - Frequency (both hands, bimanual inphase)
  - Left hand metrics (bimanual antiphase)
- Combined finger + gait features improve prediction (MAE reduction)

#### 4.1.2 Accelerometric and Clinical Data Integration

**Bayesian Ridge Regression** (González-Castro et al., 2025)
- Participants: 146 older adults
- Data types:
  - Accelerometric measurements
  - Non-accelerometric (age, comorbidities)

**Model performance:**
- Combined data: Best performance
- Bayesian Ridge: MSE 0.6746, R² 0.9941
- Non-accelerometric variables critical
- Integrated approach recommended

#### 4.1.3 Computer Vision Fall Risk Models

**LSTM-Based Gait Stability** (Chalvatzaki et al., 2018)
- Setting: Robotic rollator assistance
- Data: RGB-D + Laser Range Finder
- Features: Body pose + Center of Mass estimation

**Model:** Encoder-decoder sequence-to-sequence LSTM

**Performance:**
- Safe walking classification: >82% median AUC
- Fall risk prediction: Robust across validation
- Real-time capability for preventive intervention

**Biomechanical Spatio-Temporal GCN** (Islam et al., 2025)
- Architecture: BioST-GCN with dual-stream
- Streams:
  1. Pose information
  2. Biomechanical features
- Fusion: Cross-attention mechanism

**Performance (simulated data):**
- MCF-UA dataset: +5.32% F1 vs baseline ST-GCN
- MUVIM dataset: +2.91% F1 vs baseline
- Full supervision (simulated): 89.0% F1
- Zero-shot transfer: 35.9% F1 (simulation-reality gap)

**Challenges:**
- Simulation-reality gap significant
- Intent-to-fall biases in simulated data
- Need for personalization in elderly with diabetes/frailty

#### 4.1.4 Multi-Modal Fall Detection

**MUVIM Dataset** (Denkovski et al., 2022)
- Modalities: Infrared, Depth, RGB, Thermal
- Setting: Home environment simulation
- Approach: Anomaly detection (ADL trained only)

**Performance (AUC ROC):**
- Infrared: 0.94 (highest)
- Thermal: 0.87
- Depth: 0.86
- RGB: 0.83

**Advantages:**
- Privacy-preserving (obscured facial features)
- Low-light performance (infrared/thermal)
- Passive monitoring
- Reduced false alarms vs wearables

#### 4.1.5 Clinical Decision Support Systems

**Johns Hopkins Fall Risk Assessment Tool (JHFRAT) Enhancement** (Ganjkhanloo et al., 2025)
- Cohort: 54,209 inpatient admissions
- Hospitals: Three Johns Hopkins Health System sites
- Period: March 2022 - October 2023

**ML approach:**
- Constrained Score Optimization (CSO)
- 24-hour ICU data window
- Feature selection: RFECV + SHAP

**Performance:**
- CSO model: AUC-ROC 0.91
- JHFRAT baseline: AUC-ROC 0.86
- XGBoost benchmark: AUC-ROC 0.94
- CSO: More robust to risk label variations

**Key features:**
- Prior cerebrovascular disease
- Serum creatinine
- Systolic blood pressure

#### 4.1.6 Environmental and Biomechanical Models

**Computational Patient Room Design** (Novin et al., 2020)
- Method: Trajectory optimization for patient motion
- Input: Room layout + patient factors
- Output: Fall risk map

**Hospital Room Layout Optimization** (Chaeibakhsh et al., 2021)
- Method: Gradient-free constrained optimization
- Objective: Minimize fall risk through layout
- Approach: Simulated annealing variant

**Results:**
- 18% improvement vs traditional layouts
- 41% improvement vs random layouts
- Architectural guideline compliance
- Functional room requirements maintained

**Assistive Robot Risk-Aware Planning** (Novin et al., 2020)
- Application: Service robots for fall prevention
- Approach: Learning-based prediction + model-based control
- Risk metrics comparison for fall prevention task
- Safety-critical decision-making in healthcare

### 4.2 Gait and Mobility Analysis

#### 4.2.1 Inertial Sensor-Based Assessment

**Two-Sensor Sit-to-Stand Model** (Wairagkar et al., 2021)
- Sensors: Shank and back (only 2 IMUs)
- Model: Three-segment body model
- Method: Extended Kalman Filter + unsupervised learning

**Classification accuracy:**
- Younger healthy (YH): 98.67%
- Older healthy (OH): 94.20%
- Parkinson's disease (PwP): 91.41%

**Key achievement:**
- Thigh kinematics estimated without direct measurement
- Comfortable for extended monitoring
- Reduced power requirements
- Real-time state classification

#### 4.2.2 Fall Event Modeling

**Forward Fall Biomechanics** (Rajaei et al., 2018)
- Tool: MADYMO human body model
- Validation: Experimental vs simulation correlation
- Fall type: Forward fall with outstretched hand

**Applications:**
- Injury risk assessment
- Impact force prediction
- Safety intervention design
- Elderly-specific biomechanics

### 4.3 Activities of Daily Living (ADL)

#### 4.3.1 Video-Based Inpatient Monitoring

**Fall Risk from Bed Behavior** (Wang et al., 2021)
- Setting: Simulated hospital environment
- Data: Video frames from patient rooms
- Features: Body positions via pose estimation

**Method:**
- Human localization
- Skeleton pose estimation
- Spatial feature extraction

**Outcomes:**
- Effective body position recognition
- Pre-fall behavior identification
- Sufficient lead time for intervention
- Foundation for fall prevention programs

### 4.4 Functional Status and Outcomes

#### 4.4.1 Integrated Predictive Frameworks

**Shape and Appearance Modeling** (Bunnell et al., 2025)
- Imaging: Total-body DXA (TBDXA)
- Dataset: 35,928 scans, 5 imaging modes
- Method: Deep learning for automatic fiducial points

**Performance:**
- 99.5% correct keypoint placement
- External dataset validation

**Health marker associations:**
- Frailty indicators
- Metabolic markers
- Inflammation measures
- Cardiometabolic health

**SAM feature distributions:**
- Corroborate existing evidence
- Generate new hypotheses
- Body composition relationships
- Shape-health associations

#### 4.4.2 Readmission Risk with Spatial Factors

**Bayesian Competing Risks Model** (Shen et al., 2025)
- Population: Elderly upper extremity fracture patients
- Data: Duke Hospital EHR
- Method: GP priors for spatial effects

**Spatial analysis:**
- Point-referenced locations
- Spatially varying intercepts and slopes
- Hilbert space GP approximation
- Piecewise constant baseline hazards

**Innovation:**
- Multiplicative gamma process prior
- Loss-based clustering for high-risk regions
- Identifies geographic risk patterns
- Policy decision support

---

## 5. Key Methodological Approaches and Metrics

### 5.1 Common Machine Learning Architectures

#### 5.1.1 Deep Learning Models
- **Convolutional Neural Networks (CNN):** Image-based frailty, fall detection
- **Recurrent Networks (LSTM/GRU):** Time-series vital signs, gait analysis
- **Transformer Models:** Longformer, MAMBA for ICU monitoring
- **Large Language Models:** GPT-4, ChatGLM for clinical reasoning
- **Mixture-of-Experts:** MANDARIN for multi-state prediction

#### 5.1.2 Traditional ML Models
- **Gradient Boosting:** XGBoost, CatBoost for structured data
- **Random Forests:** Ensemble methods for robustness
- **Support Vector Machines:** Classification tasks
- **Bayesian Methods:** Uncertainty quantification, spatial modeling

#### 5.1.3 Graph-Based Models
- **Graph Convolutional Networks:** Polypharmacy side effects
- **Knowledge Graphs:** Drug-drug interactions, biomedical relationships
- **Network Models:** Frailty as complex system

### 5.2 Performance Metrics Summary

#### 5.2.1 Classification Metrics
| Metric | Typical Range (Good Performance) | Application |
|--------|----------------------------------|-------------|
| AUROC | 0.80-0.95 | Overall discriminative ability |
| AUPRC | 0.70-0.90 | Imbalanced datasets |
| Sensitivity | 75-90% | Detecting positive cases |
| Specificity | 75-90% | Avoiding false alarms |
| F1-Score | 0.75-0.90 | Balanced precision-recall |
| Accuracy | 80-95% | Overall correctness |

#### 5.2.2 Survival Analysis Metrics
- **C-Index:** 0.70-0.85 (frailty models)
- **Harrell's C-Index:** Time-dependent concordance
- **Integrated Brier Score:** Calibration over time
- **Time-dependent AUROC:** Dynamic performance

#### 5.2.3 Regression Metrics
- **Mean Squared Error (MSE):** Varies by application
- **R-squared:** >0.90 for strong predictive models
- **Mean Absolute Error (MAE):** Clinical meaningful thresholds

### 5.3 Data Sources and Preprocessing

#### 5.3.1 Major Databases
- **MIMIC-III/IV:** ICU data, broad clinical applications
- **eICU-CRD:** Multi-center ICU database
- **UK Biobank:** Population health, imaging
- **NHANES:** National health and nutrition survey
- **HRS/ELSA:** Longitudinal aging studies

#### 5.3.2 Preprocessing Strategies
- **Missing data:** SVD imputation, semantic adaptation (LLMs)
- **Class imbalance:** ADASYN, random under-sampling, SMOTE
- **Feature engineering:** Domain knowledge integration
- **Normalization:** Z-score, min-max scaling
- **Feature selection:** SHAP, RFECV, copula entropy

### 5.4 Interpretability Methods

#### 5.4.1 Post-hoc Explanations
- **SHAP (SHapley Additive exPlanations):**
  - Feature importance ranking
  - Local and global explanations
  - Interaction effects
  - Clustering in SHAP space

- **Attention Mechanisms:**
  - Temporal importance
  - Spatial focus
  - Modality contributions

#### 5.4.2 Inherently Interpretable Models
- **Constrained Score Optimization:** Clinical knowledge integration
- **Rule-based Methods:** Logical inference
- **Linear Models:** Direct coefficient interpretation
- **Decision Trees:** Transparent decision paths

---

## 6. Polypharmacy Management

### 6.1 Overview

Polypharmacy, typically defined as concurrent use of five or more medications, is highly prevalent in elderly populations and associated with increased risks of adverse drug reactions (ADRs), drug-drug interactions (DDIs), and negative health outcomes.

### 6.2 Deep Learning for Polypharmacy Side Effects

#### 6.2.1 Graph Convolutional Networks

**Decagon Model** (Zitnik et al., 2018)
- Architecture: Multimodal graph with multiple edge types
- Nodes: Proteins and drugs
- Edges:
  - Protein-protein interactions
  - Drug-protein target interactions
  - Drug-drug polypharmacy side effects

**Performance:**
- Outperforms baselines by up to 69%
- Predicts exact side effect manifestation
- Learns side effect co-occurrence patterns
- Strong performance on molecular-basis side effects

**Model characteristics:**
- Multirelational link prediction
- Parameter sharing across edge types
- Handles thousands of side effect types
- Scalable to large pharmacogenomic databases

#### 6.2.2 Tensor Factorization Approaches

**SimplE Model** (Lloyd et al., 2024)
- Performance: AUROC 0.978, AUPRC 0.971, AP@50 1.000
- Median scores across 963 side effects
- Training efficiency: 98.3% max performance in 2 epochs (~4 minutes)

**Implementation:**
- PyTorch 1.7.1 with CUDA acceleration
- Monopharmacy data as self-looping edges
- Marginal improvement over embedding initialization
- Substantially faster than existing approaches

**Tri-graph Information Propagation (TIP)** (Xu et al., 2020)
- Architecture: Three subgraphs
  1. Protein-protein graph
  2. Drug-drug graph
  3. Protein-drug graph (bridge)

**Performance improvements:**
- Accuracy: +7% over baselines
- Time efficiency: 83× faster
- Space efficiency: 3× more efficient
- Progressive information propagation

#### 6.2.3 Knowledge Graph Completion

**Multi-relational Methods** (Malone et al., 2018)
- Approach: Knowledge graph completion for polypharmacy
- Advantage: Interpretable predictions
- Best for: Well-characterized protein targets
- Output: Wet lab validation hypotheses

**BioKG Application** (Gema et al., 2023)
- Dataset: BioKG (recent biomedical knowledge graph)
- Validation: Four real-life polypharmacy tasks
- Finding: Knowledge transfer to downstream tasks effective
- Performance: 3× improvement (HITS@10) over prior work

#### 6.2.4 Advanced Neural Architectures

**ADEP (Discriminator-Enhanced)** (Kobraei et al., 2024)
- Architecture: Discriminator + encoder-decoder
- Purpose: Address data sparsity
- Advantages:
  - Enhanced feature extraction
  - Multiple classification methods
  - Outperforms GGI-DDI, SSF-DDI, LSFC, DPSP
  - Better than traditional ML (RF, KNN, LR, DT)

**Case study:** Real-world application for DDI identification

### 6.3 Neural Bandits for Polypharmacy Mining

**OptimNeuralTS** (Larouche et al., 2022)
- Method: Neural Thompson Sampling + differential evolution
- Data: Simulated dataset (500 drugs, 100k combinations)
- Goal: Search for potentially inappropriate polypharmacies (PIPs)

**Performance:**
- Detects up to 72% of PIPs
- Average precision: 99%
- Time steps: 30,000
- Efficient for large-scale screening

### 6.4 Clinical Decision Support

#### 6.4.1 ABiMed System

**Intelligent CDSS** (Mouazer et al., 2023)
- Purpose: Medication reviews and polypharmacy management
- Architecture: Multi-user collaborative system

**Components:**
1. **Automated data extraction:** GP's EHR → pharmacist
2. **Guidelines implementation:** STOPP/START rules
3. **Visual analytics:** Contextualized drug knowledge
4. **Knowledge base:**
   - Posology
   - Adverse effects
   - Drug interactions

**Advantages:**
- Associates guideline execution with visual knowledge
- Enables collaborative GP-pharmacist workflow
- Supports treatment modification suggestions
- Reduces time-consuming manual reviews

#### 6.4.2 Drug Recommendation Systems

**Safe Polypharmacy Recommendations** (Chiang et al., 2018)
- Problem formulation: To-avoid and safe drug recommendations
- Model: Joint architecture
  - Recommendation component
  - ADR label prediction component

**Output:** Drugs to avoid that would induce ADRs when combined

**Real datasets:** Drug-drug interaction databases with evaluation protocols

### 6.5 Unified Deep Learning Framework

**Relational Deep Learning** (Rozemberczyk et al., 2021)
- Review: Unified theoretical view
- Tasks addressed:
  - Polypharmacy side effect identification
  - Drug-drug interaction prediction
  - Combination therapy design

**Comparisons:**
- Model architectures
- Performance metrics
- Datasets and protocols
- Evaluation methodologies

### 6.6 ChemicalX Library

**PyTorch Deep Learning Library** (Rozemberczyk et al., 2022)
- Purpose: Drug pair scoring tasks
- Models available:
  - Weibull, Weibull AFT
  - Cox Proportional Hazards
  - Random Survival Forest
  - DeepSurv
  - Custom architectures

**Features:**
- Neural network layers for drug pairs
- Custom scoring architectures
- Data loaders and batch iterators
- Large dataset capability (100k+ compounds)
- Commodity hardware training

**Evaluation:**
- Drug-drug interaction datasets
- Polypharmacy side effect datasets
- Combination synergy predictions
- C-index and RMSE metrics

### 6.7 Knowledge Graph Construction

**VitaGraph** (Madeddu et al., 2025)
- Base: Drug Repurposing Knowledge Graph (DRKG)
- Improvements:
  - Cleaned inconsistencies and redundancies
  - Coalesced multiple public data sources
  - Enriched nodes with feature vectors
    - Molecular fingerprints
    - Gene ontologies

**Applications:**
- Drug repurposing
- PPI prediction
- Side-effect prediction
- Link prediction framework

**Advantages:**
- State-of-the-art platform
- Benchmark for graph ML models
- Biologically/chemically relevant features
- Coherent and reliable resource

---

## 7. Clinical Implementation Considerations

### 7.1 Model Deployment Challenges

#### 7.1.1 Data Quality and Availability
- Standardized data collection protocols needed
- Missing data handling strategies critical
- Multi-center validation for generalizability
- Continuous data quality monitoring

#### 7.1.2 Computational Requirements
- Real-time prediction latency constraints
- Scalability to hospital-wide deployment
- Edge computing for sensor-based systems
- Cloud infrastructure for large models

#### 7.1.3 Integration with EHR Systems
- Syntactic interoperability (data format)
- Semantic interoperability (data meaning)
- Workflow integration
- Alert fatigue management

### 7.2 Ethical and Regulatory Considerations

#### 7.2.1 Algorithmic Bias
- Demographic fairness (age, race, sex)
- Socioeconomic disparities
- Performance monitoring across subgroups
- Bias mitigation strategies

#### 7.2.2 Privacy and Security
- Patient data protection (GDPR, HIPAA)
- De-identification standards
- Secure data sharing protocols
- Federated learning approaches

#### 7.2.3 Clinical Validation
- Prospective validation studies
- Randomized controlled trials
- Clinical outcome improvement evidence
- Cost-effectiveness analysis

### 7.3 Human-AI Collaboration

#### 7.3.1 Interpretability Requirements
- Explainable predictions for clinicians
- Feature importance transparency
- Uncertainty quantification
- Reasoning trace availability

#### 7.3.2 Clinical Decision Support
- Assistive role, not autonomous decision-making
- Human oversight maintained
- Alerts prioritized by urgency
- False positive management

#### 7.3.3 User Acceptance
- Clinician training programs
- Trust building through transparency
- Feedback mechanisms for model improvement
- User interface design considerations

---

## 8. Future Directions and Research Gaps

### 8.1 Technical Innovations

#### 8.1.1 Multimodal Integration
- Combining imaging, text, time-series, and genomic data
- Cross-modal attention mechanisms
- Unified representations across modalities
- Transfer learning across data types

#### 8.1.2 Dynamic Prediction Models
- Real-time continuous monitoring
- Adaptive models that learn from new data
- Personalized trajectories
- Time-varying risk assessment

#### 8.1.3 Causal Inference
- Beyond correlation to causation
- Counterfactual reasoning
- Treatment effect estimation
- Confounding adjustment

### 8.2 Clinical Applications

#### 8.2.1 Precision Geriatric Medicine
- Individual risk stratification
- Tailored intervention strategies
- Personalized medication management
- Optimal care pathway selection

#### 8.2.2 Early Intervention Systems
- Pre-symptomatic detection
- Proactive care management
- Resource optimization
- Preventive care strategies

#### 8.2.3 Continuous Monitoring
- Wearable device integration
- Home-based assessment
- Remote patient monitoring
- Ambient sensing technologies

### 8.3 Data and Methodology Gaps

#### 8.3.1 Longitudinal Studies
- Long-term outcome tracking
- Trajectory modeling over years
- Repeated measures analysis
- Cohort effects investigation

#### 8.3.2 External Validation
- Multi-site validation studies
- International cohort testing
- Different healthcare systems
- Diverse population representation

#### 8.3.3 Simulation-Reality Gap
- Addressing biases in simulated data
- Real-world data collection protocols
- Privacy-preserving validation methods
- Transfer learning from simulation

### 8.4 Hybrid Reasoning Systems

#### 8.4.1 Symbolic-Neural Integration
- Combining knowledge graphs with neural networks
- Rule-based reasoning with learning
- Constraint satisfaction with optimization
- Logic-based explanations

#### 8.4.2 Multi-Task Learning
- Shared representations across tasks
- Joint optimization for related outcomes
- Transfer learning between conditions
- Meta-learning for new populations

#### 8.4.3 Uncertainty Quantification
- Probabilistic predictions
- Confidence intervals for risk estimates
- Epistemic vs. aleatoric uncertainty
- Decision-making under uncertainty

---

## 9. Summary of Key Performance Benchmarks

### 9.1 Frailty Assessment
- **Gait-based (MS-CNN):** 85.1% accuracy
- **Administrative data index:** AUC 0.664-0.854 (outcome-dependent)
- **Network models:** C-Index 0.70-0.85
- **Factor analysis:** Better QoL prediction than single FI

### 9.2 Delirium Prediction
- **DeLLiriuM (LLM):** AUROC 0.77-0.84 (external validation)
- **MANDARIN (MoE):** AUROC 75.5%-93.4% (outcome/cohort-dependent)
- **MAMBA (SSM):** AUROC 0.95 (ABD outcome), 0.79 (transitions)
- **Environmental factors:** AUROC 0.74-0.80

### 9.3 Mortality Prediction
- **MODS (elderly):** AUROC 0.838-0.858
- **TBI (geriatric):** AUROC 0.867
- **DM+HF comorbidity:** AUROC 0.863
- **Medicare claims:** Outperforms Cox and FRAX
- **Residential care:** AUROC 0.746 (6-month)

### 9.4 Fall Risk
- **JHFRAT enhancement:** AUROC 0.91 (vs 0.86 baseline)
- **Multimodal detection (infrared):** AUROC 0.94
- **Accelerometric + clinical:** R² 0.9941
- **Gait stability (LSTM):** AUC >0.82

### 9.5 Polypharmacy
- **SimplE tensor factorization:** AUROC 0.978
- **Decagon (GCN):** +69% improvement over baselines
- **TIP model:** +7% accuracy, 83× faster
- **ADEP:** Outperforms 14 baseline methods

---

## 10. Clinical Actionability Matrix

### 10.1 Immediate Implementation (Available Technology)

| Application | Technology Maturity | Clinical Evidence | Implementation Barrier |
|-------------|---------------------|-------------------|------------------------|
| Frailty screening (gait) | High | Moderate | Sensor cost, workflow |
| Fall risk (EHR-based) | High | Strong | EHR integration |
| Delirium prediction (24h) | High | Strong | Model deployment |
| Mortality risk (ICU) | High | Strong | Interpretability needs |
| Polypharmacy DDI check | Moderate | Moderate | Knowledge base updates |

### 10.2 Near-Term Development (2-3 Years)

| Application | Research Status | Validation Needed | Key Challenges |
|-------------|-----------------|-------------------|----------------|
| Dynamic ABD monitoring | Advanced prototype | Prospective trials | Real-time integration |
| Multimodal fall prevention | Proof of concept | Multi-site validation | Cost-effectiveness |
| Personalized frailty trajectories | Research phase | Longitudinal studies | Individual variability |
| AI-guided polypharmacy optimization | Early development | RCTs needed | Clinical acceptance |

### 10.3 Long-Term Vision (5+ Years)

| Application | Current State | Requirements | Impact Potential |
|-------------|---------------|--------------|------------------|
| Causal treatment selection | Conceptual | Causal inference methods | Very high |
| Continuous home monitoring | Prototype | Privacy-preserving tech | High |
| Integrated geriatric AI platform | Early research | Multimodal integration | Very high |
| Precision geriatric medicine | Conceptual | Genomic integration | Very high |

---

## 11. Recommendations for Acute Care Implementation

### 11.1 Priority Areas for Hybrid Reasoning Systems

1. **Delirium Prevention and Management**
   - Deploy MANDARIN-style real-time monitoring
   - Integrate environmental sensor data
   - Combine with nursing assessment scores
   - Target: 12-72 hour prediction windows

2. **Fall Risk Stratification**
   - Implement EHR-based risk scoring (JHFRAT-enhanced)
   - Add gait analysis for high-risk patients
   - Room layout optimization for identified high-risk patients
   - Continuous monitoring for mobility-impaired

3. **Frailty-Adjusted Care Planning**
   - Automated FI calculation from EHR
   - Multi-dimensional frailty assessment
   - Trajectory prediction for care planning
   - Resource allocation optimization

4. **Polypharmacy Safety**
   - Real-time DDI checking with Decagon-style models
   - Knowledge graph-based decision support
   - ABiMed-style collaborative medication review
   - Integration with prescribing workflows

5. **Mortality Risk Communication**
   - Interpretable models (SHAP-based explanations)
   - Uncertainty quantification (Bayesian approaches)
   - Time-varying risk estimates
   - Family/patient communication tools

### 11.2 Data Infrastructure Requirements

1. **Data Collection**
   - Standardized EHR data extraction
   - Sensor integration framework
   - Imaging data pipeline
   - Real-time data streaming

2. **Data Quality**
   - Missing data monitoring
   - Automated quality checks
   - Bias detection systems
   - Continuous validation

3. **Data Security**
   - Privacy-preserving analytics
   - Secure multi-party computation
   - Federated learning infrastructure
   - Audit trails and governance

### 11.3 Model Development and Validation

1. **Internal Development**
   - Start with high-maturity models
   - Focus on interpretable approaches
   - Prioritize clinical validation
   - Ensure model monitoring

2. **External Collaboration**
   - Academic partnerships for innovation
   - Industry partnerships for deployment
   - Multi-center validation networks
   - Open-source contributions

3. **Continuous Improvement**
   - Model performance monitoring
   - Drift detection and retraining
   - Feedback loops from clinicians
   - Patient outcome tracking

### 11.4 Clinical Workflow Integration

1. **Alert Management**
   - Prioritized alert system
   - Configurable thresholds
   - Alert fatigue prevention
   - Clear action recommendations

2. **Decision Support**
   - Embedded in clinical workflow
   - Context-aware recommendations
   - Evidence-based justifications
   - Override capability with documentation

3. **Clinician Training**
   - Model interpretation education
   - Appropriate use guidelines
   - Ongoing support
   - Feedback mechanisms

---

## 12. Conclusion

The application of artificial intelligence and machine learning to geriatric care has demonstrated remarkable progress across multiple domains including frailty assessment, delirium prediction, fall risk stratification, polypharmacy management, and mortality prediction. Current models achieve impressive performance metrics, with many exceeding traditional clinical scoring systems.

### Key Strengths:
- **High discriminative ability:** AUROC values consistently >0.80 for well-developed models
- **Interpretability advances:** SHAP, attention mechanisms enable clinical trust
- **Multi-modal integration:** Combining imaging, sensors, EHR data improves accuracy
- **Real-time capability:** Transformer and state-space models enable continuous monitoring
- **Scalability:** Methods validated across multiple hospitals and large cohorts

### Remaining Challenges:
- **Implementation gaps:** Translation from research to clinical practice
- **Algorithmic bias:** Performance disparities across demographic groups
- **Simulation-reality gap:** Particularly for fall and mobility models
- **Data quality:** Missing data, inconsistent coding, limited longitudinal follow-up
- **Clinical acceptance:** Need for interpretability and workflow integration

### Future Opportunities:
- **Hybrid reasoning systems:** Combining symbolic and neural approaches
- **Causal inference:** Moving beyond prediction to intervention optimization
- **Personalized medicine:** Individual trajectory prediction and tailored interventions
- **Continuous monitoring:** Home-based and wearable-device integration
- **Multi-objective optimization:** Balancing multiple clinical outcomes simultaneously

The reviewed literature provides a strong foundation for developing comprehensive AI systems for geriatric acute care. The combination of robust predictive models, interpretable outputs, and attention to clinical workflow integration positions these technologies for meaningful impact on patient outcomes, healthcare efficiency, and quality of care for elderly populations.

For hybrid reasoning systems specifically, the integration of rule-based knowledge (clinical guidelines, drug interaction databases) with data-driven learning (neural networks, graph models) represents a particularly promising direction. Such systems can leverage the strengths of both approaches: the interpretability and domain knowledge of symbolic reasoning combined with the pattern recognition and adaptability of machine learning.

---

## References

This review synthesized findings from 70+ research papers published between 2016-2025, focusing on recent advances in AI applications for geriatric care. Papers were selected from arXiv database searches targeting frailty assessment, fall risk prediction, delirium detection, polypharmacy management, and outcome prediction in elderly populations.

### Key Database Sources:
- MIMIC-III and MIMIC-IV: Medical Information Mart for Intensive Care
- eICU-CRD: Electronic ICU Collaborative Research Database
- UK Biobank: Large-scale biomedical database
- NHANES: National Health and Nutrition Examination Survey
- HRS: Health and Retirement Study
- ELSA: English Longitudinal Study of Ageing
- MrOS: Osteoporotic Fractures in Men Study
- SOF: Study of Osteoporotic Fractures

### Performance Metric Abbreviations:
- AUROC: Area Under Receiver Operating Characteristic Curve
- AUPRC: Area Under Precision-Recall Curve
- FI: Frailty Index
- DDI: Drug-Drug Interaction
- ADR: Adverse Drug Reaction
- ABD: Acute Brain Dysfunction
- TBI: Traumatic Brain Injury
- MODS: Multiple Organ Dysfunction Syndrome
- ADL: Activities of Daily Living
- EHR: Electronic Health Record

---

*Document generated: 2025-12-01*
*Total pages: ~45 (estimated)*
*Total lines: ~490*
*Word count: ~6,800*